Stem cells have the surprising potential to develop into many different cell types. Therefore, major research efforts have focused on transplantation of stem cells and/or derived progenitors for restoring depleted diseased cells in degenerative disorders. Understanding the molecular controls, including alternative splicing, that arise during lineage differentiation of stem cells is crucial for developing stem cell therapeutic approaches in regeneration medicine. Alternative splicing to allow a single gene to encode multiple transcripts with different protein coding sequences and RNA regulatory elements increases genomic complexities. Utilizing differences in alternative splicing as a molecular marker may be more sensitive than simply gene expression in various degrees of stem cell differentiation. Moreover, alternative splicing maybe provide a new concept to acquire induced pluripotent stem cells or promote cell-cell transdifferentiation for restorative therapies and basic medicine researches. In this review, we highlight the recent advances of alternative splicing regulation in stem cells and their progenitors. It will hopefully provide much needed knowledge into realizing stem cell biology and related applications.
INTRODUCTION
exist in many tissues and can differentiate into a variety of cell types. Neural stem cells (NSCs) have been isolated from various areas of the adult brain and possess Presently, stem cells are recognized by many researchers as having virtually unlimited application in the the ability to differentiate along neuronal and glial lineages. In addition, induced pluripotent stem cells (iPSs) treatment and cure of many human diseases and disorders, including stroke (12, 26, (50) (51) (52) (53) (54) (55) (56) 58 ), Parkinson's artificially derived from nonpluripotent cells are the novel type of pluripotent stem cells. disease (19) , Alzheimer's disease (36), diabetes (13, 43) , cancer (24) , and so on. Stem cells are original cells with Understanding the molecular control of gene expression by chromatin modification, transcription factors, an extended self-renewal capacity and the power to develop into multiple cell types. There are two general posttranscriptional regulation by alternative splicing and microRNAs, and posttranslational modification that types. Embryonic stem cells (ESCs) derive from the inner cell mass of a blastocyst and can differentiate into arise during differentiation of stem cells and their progenitors is important for developing stem cell therapeuall kind of cells in the animal. Second are adult stem cells, which are found in mature animal body and have tic approaches in regenerative medicine. Splicing is a modification of pre-mRNA of eukaryotic cell after tranlimited potency. For instance, hematopoietic stem cells (HSCs) are found in the bone marrow and give rise to scription, in which introns are removed and exons are joined. It can be used to produce a correct protein all the blood cell types. Mesenchymal stem cells (MSCs) through translation. Splicing is mainly catalyzed by the and breast cancer cells. CD44 isoforms that include the cassette exon v5 are connected with enhanced maligspliceosome, a complex of five small nuclear RNAs (snRNAs) and numerous protein factors (snRNPs), but nancy and invasiveness (30, 31) . A chemokine, CXCL12α, importantly promotes the oriented cell migration and tisthere are also self-splicing introns. The main spliceosome binds to the pre-mRNA in a sequential manner, in sue homing of many cell types through interactions with CXCR4 receptor and heparan sulfate (HS). The AS isothe order of U1, U2, and then tri-snRNA particle of U4/ U6.U5. Subsequent to the binding of tri-snRNA, the form of CXCL12α, CXCL12γ, having the high happening of basic residues, could characterize specific adjustspliceosome undergoes a violent structural rearrangement, including the release of U1 and U4, and the addiment by HS and is optimized to ensure its strong retention at the cell surface (29) . AS events spread in eukaryotic tion of the Prp19-associated complex (NTC), and becomes a catalytic spliceosome. The catalytic spliceosome cells; it is not surprising that AS is important in both development and related disease. Many human diseases promotes two sequential transesterification reactions. First, the 2′OH of a specific branch-point nucleotide develop from abnormal splicing of crucial transcripts or the appearance of deficient splice isoforms in affected within the intron performs a nucleophilic attack on the first nucleotide of the intron at the 5′ splice site to form tissues (63). Examples of disease genes include cystic fibrosis transmembrane conductance regulator (CFTR), the lariat intermediate. Second, the 3′OH of the released 5′ exon then carries out a nucleophilic attack at the last microtubule-associated protein tau (MAPT), survival of motor neuron 1 (SMN1), etc. (5). The related therapeutic nucleotide of the intron at the 3′ splice site, thus joining the exons and releasing the intron lariat. After the two approaches used AS are present (16) . The most genetic and biochemical studies about contransesterification reactions are complete, the postcatalytic spliceosome first releases the mature mRNA and trol of AS have been shown in yeast, flies, nematode, mouse, rat, and human model (3). It is easy to predict then combines NTR complex to disassemble all components for a new round of splicing (60, 61) .
splice sites by screening a pre-mRNA sequence and looking for consensus splice sites. Interestingly, exons Alternative splicing (AS) is the splicing variation mechanism. Exons of pre-mRNAs are linked by AS in flanked by the right consensus splice sites are not always spliced. Conversely, exons flanked by weak consensus different order and produce a large number transcripts with different protein coding sequences and RNA regusplice sites are sometimes spliced well. This phenomenon can be answered that splicing is affected by helping latory elements. Several common types of AS, including cassette exons, mutually exclusive exons, competing 5′ sequences that assist to define real exons. These helping sequences are cis-regulatory elements located in the exosplice sites, competing 3′ splice sites, and retained introns, are illustrated in Figure 1 (5, 28, 37) . In addition, nic and intronic regions of the gene. They are also called splicing codes and contain the exonic and intronic splice the use of different promoters or different polyadenylation sites can also result in AS (Fig. 1) . After AS, mature enhancers (ESEs and ISEs, respectively) and conversely exonic and intronic splice silencers (ESSs and ISSs, remRNA often results in a frameshift, in the use of a different start or stop codon, and in the modification of 5′ spectively), as illustrated in Figure 2 (5, 41, 64) . Splice enhancers and silencers are recognized by and 3′ untranslated regions of mRNAs containing different regulatory elements affecting mRNA translation, statrans-acting splicing factors. These factors are RNA binding proteins (RNABPs) that include the SR proteins bility, and localization (5, 28, 37) . Some articles reported one third of annotated AS transcripts produced premaand the hnRNP proteins. They determine the use and/or skip of splice sites and recognize splice enhancers and ture termination codons (PTCs) and suffered nonsensemediated decay (AS-NMD) (39) .
silencers by combinatorial binding. Binding sequences of some RNABPs have been characterized. The FOX Many studies showed that up to 74% of human genes suffer AS, with noticeable variation across tissue types proteins bind UGCAUG; PTB proteins interact with UCUCU; hnRNP A/B bind GGGG; TIA-1 associates Uand developmental stages (25) . AS of genes involved in angiogenesis, adhesion, apoptosis and invasion, metastarich sequences, muscleblind (MBNL) proteins attach UGCU; SUP-12 (RBM38) and the CELF proteins intersis, proliferation, and hormone signaling is now well documented (5, 28, 37) . For example, an antiangiogenic act with UGUGU; and neuronal Nova RNA binding proteins bind either YCAY or YCATY (Y, pyrimidine) family of VEGF AS isoforms was found, and named VEGF XXX b. VEGF XXX b isoforms originate from an alter-(10). Relative ratio of various trans-acting splicing factors can affect AS. For example, the SR protein SF2/ native 3′ splice site in exon 8 of VEGF, differing by only six amino acids at the C-terminus. This AS se-ASF and the protein hnRNPA1 compete for binding to pre-mRNA. When SF2 is less than hnRNPA1, exon quence radically changes the functional properties of VEGF (28). The AS isoforms of cell adhesion molecule skipping is major, but when SF2 is more than hnRNPA-1, exon joining is favored (28). Many posttranscriptional and metastatic effector CD44 is discovered in prostate and posttranslational mechanisms, such as AS-NMD, tion techniques, that permit the large-scale profiling of AS (5) . AS arrays allow multiple probes to hybridize miRNA, ubiquitination, SUMOylation, and phosphorylation, controlling trans-acting splicing factors expreswith the exon-exon junctions. These arrays contain probes within constitutive exons so that transcripts can sion and cellular localization indicate possible autoregulatory organization at the level of splicing (41) (Fig. 3) .
be assessed as present or absent of the exon junction from the sample after hybridization (41) (Fig. 4 ). MoreAlthough many studies on the functions and mechanism of AS that are related with specific transcripts, sysover, combining microarray analysis to molecular techniques such as chromatin and RNA immunoprecipitation tematically elucidating the roles of AS events, are only now beginning to be used. Expressed sequence tags and can discover populations of genes and transcripts regulated by specific trans-acting splicing factors (41) . cDNA sequences can be aligned to genomic sequences. Then the transcripts with or without middle exon alignUsing microarrays and computational tools, we have novel insights about means of AS modulation. First, for ments can be systematically recognized. But EST coverage associated with AS events is typically biased toward different cell types and differentiation stages, the patterns of AS and relative ratio of specific trans-acting the 3′ and 5′ ends of transcripts, and there are not enough numbers of sequenced transcripts to deduce the splicing factors are reproducible marks. Second, the patterns of AS and relative ratio of specific trans-acting frequency with which specific AS exons are included or skipped. At present, custom microarrays and computasplicing factors are dynamic and in response to intraand extracellular signals. Third, functionally related trantional tools have overcome some of the limitations in the analysis of EST/cDNA, like differential hybridizascripts can be coregulated in splicing networks to pro- Induction or skipping of an exon is determined by the balance of these elements' competing effects, which in turn might be determined by relative concentrations of specific trans-acting splicing factors.
mote specific biological functions (41) . In this review, tion into smooth muscle cells (SMCs). Platelet-derived growth factor enhanced ES cell differentiation into we focused on the mechanism of AS in stem cell differentiation. Regulation of AS in multiple stem cells is disSMCs through increase of HDAC7 splicing. The data revealed that HDAC7 splicing induced SMC differentiacussed below.
tion through regulation of the SRF-myocardin complex TRANSCRIPTOME DIVERSITY AND (35) .
ALTERNATIVE SPLICING OF STEM CELLS
Fibroblast growth factor 4 (FGF4) is a key candidate of autocrine message and is expressed by undifferentiUsing AS microarrays, some researchers compared transcriptional profiles in different stem cell lines and ated hESC lines. When recombinant FGF4 adds to hESCs, cells proliferation is promoted. FGF4si is a studied expression changes during the differentiation of stem cells to various lineage-committed cells (2,7,8,15, novel FGF4 AS isoform and translates for the aminoterminal half of FGF4. FGF4si is an antagonist of FGF4, 27,40,66). These studies showed that many genes were upregulated or downregulated during stem cells proclosing FGF4-induced Erk1/2 phosphorylation. FGF4si effectively counters FGF4 effect in undifferentiated gramming and differentiation through AS. At different stages of differentiation, AS generates different tranhESCs. The expression investigation shows that both isoforms are expressed in hESCs and early differentiated scripts and often contributes to the regulation of gene expression by generating tissue-specific mRNA and procells. FGF4si continues to be expressed after cell differentiation, whereas FGF4 is not. Using siRNA knocktein isoforms (3, 9, 22, 68) . Hence, it is interesting that AS plays important roles in regulating lineages gene expresdown of FGF4 increased differentiation of hESCs (38).
CoAA is a splicing coactivator that regulates presion and function (4, 21) . In the splicing field, the next step attempts to identify and sort extensive AS isoforms mRNA splicing. CoAA gene is expressed in hESCs and processes AS in different tissues to three AS isoforms: in various stages of stem cell differentiation.
CoAA, CoAM, and CoAR. The expression of CoAA un-EMBRYONIC STEM CELLS dergoes a rapid change to its dominant negative splice variant CoAM in the embryoid body cavity during retiHistone deacetylase 7 (HDAC7) has an essential role in the regulation of gene expression on ESCs differentianoic acid-induced P19 stem cell differentiation. CoAM (45) . In addition, the C-termiinduced at later developmental stages than vHnf1 and its deficit does not result in embryonic lethality or developnal sequence of 4.1R encoded by exons 20 and 21 contains a binding region for nuclear mitotic apparatus promental defects. vHNF1 displays specific behavior depending on particular target genes and assists in the ortein (NuMA) and also produces two AS isoforms. CO.1 lacks most of exon 20-encoded sequence with a misganization of a functional visceral endoderm (23) .
Tonicity-responsive enhancer binding protein (Tosense C-terminal sequence. However, CO.2 has the normal exon 21-encoded C-terminal sequence without exon nEBP)-nuclear factor of activated T cell family 5 (NFAT5) is a DNA binding protein that plays a impor-20-encoded C-terminal sequence and assembles to spindle poles, and colocalizes with NuMA in erythroid and tant role in the response of cells to hypertonicity. TonEBP existed in ESCs and the stages of fetal developlymphoid mutated cells (18). Moreover, during erythropoiesis, activation of protein 4.1R exon 16 (E16) inclument. Extensive AS in exons 2-4 was detected during development and in different adult tissues. Four AS isosions shows a physiologically important AS that enhances 4.1R binding spectrin and actin in the red blood formes are produced with different lengths at the Nterminus. Two of the isoforms differ in their ability to cell membrane biogenesis. Upregulation of E16 splicing can be controlled by Fox-2 or Fox-1, two related splicstimulate transcription (34) .
Protein kinase Cδ (PKCδ) plays an essential role as ing factors that hold the same RNA recognition motif, UGCAUG in the proximal intron downstream of E16, a regulator of cellular apoptosis in response to various stimuli. PKCδI is proteolytically cut at its hinge region and both could induce E16 splicing. Downregulation of E16 splicing is controlled by the binding of hnRNP A/B (V3) by caspase 3 and the fragment is enough to stimulate apoptosis in various cell types. Interestingly, mouse proteins to ESS and that downregulation of hnRNP A/B proteins in erythroblasts results in activation of E16 in-AS isoform PKCδII resists caspase cut because there is an insertion of 78 bp within the caspase recognition site clusion (17, 47) . Chronic myelogenous leukemia (CML) is a tumor of in its V3 domain. Overexpression of PKCδI promotes apoptosis, but PKCδII overexpression inhibits the cells HSCs induced by the p210BCR/ABL protein. BCR/ ABL promoted the expression of multiple genes infrom apoptosis. In NT2 cells, retinoic acid regulates the expression of PKCδ AS variants (46) . volved in pre-mRNA splicing. β-Integrin signaling is essential to HSC maintenance and proliferation/differen-HEMATOPOIETIC STEM CELLS tiation, and is abnormal in CML. AS of β1-integrinresponsive nonreceptor tyrosine kinase gene (Pyk2) Acute myeloid leukemia 1 (AML1, or runt-related transcription factor, RUNX1) plays a fundamental role enhanced expression of full-length Pyk2 in BCR/ABLcontaining cells. This may induce CML pathogenesis for definitive hematopoiesis encoding the DNA binding subunit of the heterodimering transcription factor com- (48) . CD133 is a novel protein in cell surface. The function plex PEBP2 (CBF). Transcription of AML1 is restricted by two distinct promoter sequences, which lead to proof CD133 is not clear, but its expression in the hematopoietic system is limited to CD34 + stem cells. The huduce the respective AML1b and AML1c isoforms. AML1b exists in undifferentiated ESCs and upregulated man CD133 gene has at least nine exons with different 5′-untranslated region (UTR), leading to form at least in the early developmental stage, but AML1c expression is the slow upregulation and steady maintenance during seven 5′-UTR AS transcripts of CD133, which are expressed in a tissue-specific manner (49) . It suggests difembryogenesis. These two AS isoforms, driven by their ferent roles for these transcripts in fetal development in a mutually exclusive fashion. PTB directly blocks nPTB expression in nonneuronal cells by preventing and mature organ homeostasis (67) .
The c-Myb transcription factor controls the proliferaexon 10 of nPTB inclusion, which introduces a PTC, thereby degrading nPTB mRNA via AS-NMD (33) . tion and differentiation of hematopoietic cells, and activation of c-myb promotes leukemias and lymphomas in However, a neuronal-enriched microRNA (mir-124) directly binds the 3′-untranslated region of PTB, closes animals. Relatively minor changes through AS in the cMyb protein structure can change the genes expression PTB expression, and promotes neuronal differentiation of mouse P19 cells. These data identified a "posttranthat it regulates and can let loose its latent transforming activities. The c-Myb isoform showed differences in scriptional control" that reprograms AS during neuronal development. transcriptional activities and specificities. AS of c-myb may be a mechanism for its transforming activity change Mammalian Numb (mNumb) has multiple functions and plays key roles, including maintenance of neural in human leukemias (44) .
progenitor cells and promotion of neuronal differentia-NEURAL STEM CELLS tion in the central nervous system (CNS). mNumb has two type AS isoforms based on the presence or absence Sam68 (Src-associated in mitosis, 68 kDa) is a KH domain RNABP involved in a variety of cellular funcof the specific amino acid in the proline-rich region (PRR) of the C-terminus. The human Numb isoform of tions, including AS. Using RNAi of Sam68 and AS microarrays, researchers recognized some alternative exons long PRR domain (hNumb-PRRL) is mainly expressed during early neurogenesis in the CNS to promote prolifwhose splicing depends on Sam68. Precise analysis of one newly identified target exon in epsilon sarcoglycan eration of both neuroepithelial cells and postembryonic neuroblasts without affecting neuronal differentiation. (Sgce) showed that both RNA elements distributed across the adjacent introns. The RNA binding activity
The human Numb isoform of short PRR domain (hNumb-PRRS) is expressed throughout neurogenesis in of Sam68 is essential to suppress the Sgce exon. Sam68 protein is increased upon neuronal differentiation of P19 the embryonic CNS, inhibits proliferation of the stem cells, and induces neuronal differentiation. Some studies cells, and many RNA targets of Sam68 alter in expression and splicing during this process. When Sam68 is showed that hNumb-PRRS more strongly downregulated the amount of nuclear Notch than hNumb-PRRL, knocked down, many Sam68-dependent splicing changes do not occur and P19 cells are unsuccessful to differentiand could antagonize Notch functions, probably through endocytic degradation. The two different types of ate. The differentiation of primary neuronal progenitor cells from embryonic mouse neocortex is repressed by hNumb isoforms could support different phases of neurogenesis in the embryonic CNS (59). Sam68 depletion and induced by Sam68 overexpression. Thus, Sam68 controls neurogenesis through its influ-CONCLUSION ences on many specific AS of RNA targets (14) .
Tenascin C (Tnc) is a multimodular extracellular maUnderstanding mechanisms of controlling stem cell differentiation will help us to develop effective stem trix glycoprotein that exists in the ventricular zone of the developing brain. More than 25 different Tnc AS cell-based therapies. The previous several years, microarray studies have mainly compared with differences exisoforms were well known in NSCs. After overexpression of homeodomain protein Pax6, the larger Tnc AS pression of genes in various stem cell and somatic cell populations. However, the posttranscriptional regulaisoforms inclusion additional fibronectin type III domains were upregulated, whereas the smaller Tnc AS tions of transcriptome-related differentiation of stem cells remained unclear. In the future, work to characterisoforms without any or with one additional fibronectin type III domain were downregulated (62). In addition, ize AS mechanism-related stem cell differentiation will be in several ways. One is to produce an extensive data Sam68 as a target of Tnc signaling in NSCs and its overexpression also selectively increased the larger Tnc isopool of AS variants in stem cells and their lineages. A second it to identify cis-regulatory elements and transforms (42) .
The polypyrimidine tract-binding protein (PTB/ acting splicing factors of AS involved in stem cell differentiation. A third is to characterize the signaling path-PTBP1) is important in keeping nonneuronal cells and blocks nonneuronal cells to differentiate into neurons ways and regulation mechanism involved in expression and activity of trans-acting splicing factors in stem cell (6, 33, 57) . PTB is a splicing repressor on neuron-specific exon (1) . When PTB protein knocked down, neuronaldifferentiation. In addition, utilizing different AS patterns and relative ratio of specific trans-acting splicing specific AS of nonneuronal cells was sufficient to trigger. Interestingly, neurons express an antagonist of PTB, factors as a molecular marker of stem cells differentiation will be a good ideal. Presently, reprogramming of a nPTB (PTBP2), which acts as a weaker splicing repressor compared with PTB. PTB and nPTB are expressed somatic cell to an ESCs-like state by overexpression of 
